saralasin acetate

saralasin acetate (SARENIN) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

SARENIN is a marketed brand name for saralasin acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

saralasin acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.